Continuing Education Company Primary Care On Demand Diabetes Volume 3 2023
Include: 12 videos + 12 pdfs, size: GB
Target Audience: primary care and family medicine physicians
Information:
Empower your diabetes management skills with Primary Care On Demand: Diabetes Vol. 3. Tailored for primary care clinicians, this comprehensive online course provides an essential update on type 2 diabetes-related issues frequently encountered in internal medicine and family medicine practice. From the latest guidelines to innovative treatments and case discussions, immerse yourself in the practical, patient-focused insights necessary for promoting improved outcomes in the primary care setting.
Program Overview
Primary Care On Demand: Diabetes Volume 3 highlights the latest science related to diabetes, presented in a practical and patient-focused manner relevant to the primary care setting. Topics include Type 2 Diabetes Guidelines, Pathophysiology-Based Treatment, SGLT2 Inhibitors and GLP-1 Receptor Agonists, Latest Trials on Older Drugs, Contrasting the GLP-1 and Dual Incretin Receptor Agonists with SGLT2 Inhibitors in Early Treatment, Novel Medications for Resistant Hypertension, A Cardiometabolic Approach for Older Outpatient with Diabetes, 21st Century Approach to Halting Nephropathy, and Cases in Diabetes, Kidney, and Cardio-Renal Disease.
Key Features
- Engaging content from renowned experts
- Personalized learning experience – learn at your own pace, on your own schedule, and in your preferred environment.
- 10 HD-quality video-based lectures and presentation handouts
- Accessible anywhere, anytime – stream online or download for viewing at your leisure
Course Objectives
As a result of this educational activity, participants should be better able to:
- Formulate an efficient and effective assessment and monitoring plan of a patient’s condition as it relates to diabetes.
- Utilize current guidelines in the diagnosis and management of diabetes.
- Develop individualized interventions and treatment strategies for patients presenting with diabetes that will lead to the reduction of modifiable risk factors and improved long-term outcomes.
Target Audience
This activity is designed for physicians, nurse practitioners, physician assistants and other healthcare professionals specializing in primary care and family medicine.
Topics:
Session | Title | Faculty |
Session 1 (47 minutes) | Type 2 Diabetes Guidelines | S. Inzucchi, MD |
Session 2 (44 minutes) | Treatment of Type 2 Diabetes: A Sound Approach Based on Its Pathophysiology | J. Buse, MD, PhD |
Session 3 (44 minutes) | Practical Aspects of Using Newer Diabetes Medications: SGLT2 Inhibitors and GLP-1 Receptor Agonists | S. Inzucchi, MD |
Session 4 (49 minutes) | Type 2 Diabetes: What Have the Latest Trials on Older Drugs Told Us? | J. Buse, MD, PhD |
Session 5 (63 minutes) | Cases in Diabetes | J. Buse, MD, PhD & S. Inzucchi, MD |
Session 6 (62 minutes) | Contrasting the GLP-1 and Dual Incretin Receptor Agonists with SGLT2 Inhibitors in the Early Treatment of Diabetes | M. McDonnell, MD |
Session 7 (46 minutes) | Novel Medications for Resistant Hypertension: What the Future Holds | G. Bakris, MD |
Session 8 (47 minutes) | Selecting Therapies in the Older Outpatient with Diabetes: A Cardiometabolic Approach | M. McDonnell, MD |
Session 9 (58 minutes) | “Pillars of Therapy”: The 21st Century Approach to Halting Nephropathy from Diabetes | G. Bakris, MD |
Session 10 (81 minutes) | Cases in Diabetes, Kidney, and Cardio-Renal Disease | M. McDonnell, MD & G. Bakris, MD |